Ipsen: all 356 studies
Page 2 of 4. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.
- Comparing Lower-concentration Dysport Treatment Targeted to the Neuromuscular Junction With Current Clinical PracticeTerminatedNCT01682148Phase 3Results posted
- GP Extended Action TriptorelinTerminatedNCT01673984Phase 4Results posted
- Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate CancerTerminatedNCT01374087Phase 2Results posted
- Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple SclerosisCompletedNCT01357980Phase 2Results posted
- Safety and Efficacy Study of Dysport RU and Glabellar LinesCompletedNCT01333397Phase 2Results posted
- Dysport® Adult Upper Limb Spasticity Extension StudyCompletedNCT01313312Phase 3Results posted
- Dysport® Adult Upper Limb SpasticityCompletedNCT01313299Phase 3Results posted
- Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer PatientsTerminatedNCT01313273Phase 3Results posted
- Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical DystoniaCompletedNCT01261611Phase 3Results posted
- Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mgCompletedNCT01257425Phase 2Results posted
- Dysport® Pediatric Lower Limb Spasticity Follow-on StudyCompletedNCT01251380Phase 3Results posted
- Dysport® Adult Lower Limb Spasticity Follow-on StudyCompletedNCT01251367Phase 3Results posted
- Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapyTerminatedNCT01251354Phase 2Results posted
- Dysport® Pediatric Lower Limb Spasticity StudyCompletedNCT01249417Phase 3Results posted
- Dysport® Adult Lower Limb Spasticity StudyCompletedNCT01249404Phase 3Results posted
- Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate CancerCompletedNCT01020448Phase 3Results posted
- Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid SyndromeTerminatedNCT01018953Phase 2Results posted
- Study of Elobixibat (A3309) in Patients With Chronic Idiopathic ConstipationCompletedNCT01007123Phase 2Results posted
- Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With AcromegalyTerminatedNCT00994214Phase 2Results posted
- The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial CancerCompletedNCT00910091Phase 2Results posted
- Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up StudyCompletedNCT00909844Phase 3Results posted
- Lanreotide Autogel in the Symptomatic Treatment of Refractory DiarrheaCompletedNCT00891371Phase 2/3Results posted
- Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine TumourCompletedNCT00842348Phase 3Results posted
- Efficacy of EGb761 in Patients Suffering From Friedreich AtaxiaCompletedNCT00824512Phase 2Results posted
- Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive FunctionsCompletedNCT00814346Phase 2Results posted
- An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid SyndromeCompletedNCT00774930Phase 3Results posted
- Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic SubjectsCompletedNCT00701363Phase 4Results posted
- Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland MacroadenomaCompletedNCT00690898Phase 3Results posted
- Somatuline Autogel Preference and Health Economy StudyCompletedNCT00681187Phase 4Results posted
- rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 DeficiencyTerminatedNCT00572156Phase 2Results posted
- Long-Term Treatment With rhIGF-1 in GHISCompletedNCT00571727Phase 2/3Results posted
- Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious PubertyCompletedNCT00564850Phase 3Results posted
- Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and TreatmentCompletedNCT00489255Phase 4Results posted
- Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar FasciitisCompletedNCT00447876Phase 2/3Results posted
- Study to Assess the Efficacy and Safety of Dysport® in Cervical DystoniaCompletedNCT00447772Phase 3Results posted
- Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline AutogelCompletedNCT00447499Phase 3Results posted
- Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic PatientsCompletedNCT00383708Phase 3Results posted
- Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine TumoursCompletedNCT00353496Phase 3Results posted
- Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 DeficiencyTerminatedNCT00330668Phase 3Results posted
- Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical DystoniaCompletedNCT00288509Phase 3Results posted
- A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic StrokeCompletedNCT00276380Phase 3Results posted
- Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical DystoniaCompletedNCT00257660Phase 3Results posted
- Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAqCompletedNCT00234533Phase 3Results posted
- Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 DeficiencyCompletedNCT00125190Phase 2/3Results posted
- Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) DeficiencyCompletedNCT00125164Phase 3Results posted
- Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)Active, not recruitingNCT07497724
- A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain TumoursActive, not recruitingNCT07441707Phase 1
- A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsActive, not recruitingNCT07435428Phase 3
- A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsActive, not recruitingNCT07427797Phase 3
- Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two TherapiesWithdrawnNCT07282548
- A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in SpainCompletedNCT07191704
- A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)CompletedNCT07049887
- A Study of the Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single DoseCompletedNCT06908954Phase 1
- A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid TumoursActive, not recruitingNCT06833008Phase 1/2
- A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)Active, not recruitingNCT06730061Phase 3
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in AdultsActive, not recruitingNCT06625060Phase 2
- A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing TreatmentActive, not recruitingNCT06447168
- A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.CompletedNCT06383403Phase 3
- Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With OsteosarcomaTerminatedNCT06341712Phase 2
- A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid TumoursActive, not recruitingNCT06305247Phase 1/2
- A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and AcromegalyCompletedNCT06253897
- CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb SpasticityActive, not recruitingNCT06245772
- A Study to Assess Efficacy and Safety of Oral Tazemetostat in Adult Participants With Relapsed/Refractory Follicular Lymphoma That Does Not Have an "EZH2 Gain-of-function" Genetic MutationWithdrawnNCT06068881Phase 2
- A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its DevelopmentActive, not recruitingNCT06055725
- A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in AdultsActive, not recruitingNCT06047457Phase 3
- A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in AdultsActive, not recruitingNCT06047444Phase 3
- A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NETTerminatedNCT05922579
- Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant RecipientsCompletedNCT05769582Phase 2/3
- A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in ItalyCompletedNCT05759273
- Study of Navtemadlin Plus Pembrolizumab as Maintenance Therapy in Locally Advanced and Metastatic Non-Small Cell Lung CancerWithdrawnNCT05705466Phase 1/2
- A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.Active, not recruitingNCT05627362Phase 2
- A Study to Evaluate the Effect of Food on the Level of Circulating Elafibranor in Healthy Participants After Intake of a Single TabletCompletedNCT05564208Phase 1
- A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)CompletedNCT05546190
- Study to Compare the Level of Elafibranor in Blood After Repeat Administration in Japanese and Non-Asian Healthy ParticipantsCompletedNCT05543369Phase 1
- A Study to Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France.CompletedNCT05444933
- Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in ChinaCompletedNCT05431803
- An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary AtresiaActive, not recruitingNCT05426733Phase 3
- A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the PancreasCompletedNCT05383352Phase 1
- Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer TreatmentCompletedNCT05377684
- A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in AdultsCompletedNCT05361434
- Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers.CompletedNCT05358106Phase 1
- To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.CompletedNCT05351437Phase 1
- Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid TumorsTerminatedNCT05307874Phase 1/2
- Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.CompletedNCT05224349
- A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer.WithdrawnNCT05205252Phase 1/2
- Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in ChinaWithdrawnNCT05184231
- A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United Kingdom (UK).CompletedNCT05169775
- A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).TerminatedNCT05039515Phase 2
- Long-term Safety and Efficacy of Odevixibat in Patients With Alagille SyndromeActive, not recruitingNCT05035030Phase 3
- KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung CancerTerminatedNCT05027867Phase 2
- Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing CombinationCompletedNCT04957160
- Study to Compare the Pharmacokinetics, Safety, and Tolerability Following Administration of Palovarotene in Healthy Japanese and Non-Asian SubjectsCompletedNCT04829786Phase 1
- Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult SubjectsCompletedNCT04829773Phase 1
- A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial LinesActive, not recruitingNCT04821089Phase 1/2
- Study to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Palovarotene Ophthalmic Solution in Healthy Adult SubjectsCompletedNCT04762355Phase 1
- Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Facial Lines.TerminatedNCT04736745Phase 1
- An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.CompletedNCT04665323
- Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From a Real-world Healthcare Insurance Database.CompletedNCT04649632
- United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration SettingCompletedNCT04649580
- Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in EnglandCompletedNCT04637204